Johns Hopkins neurosurgeons and biomedical engineers work to create wearable and implantable devices enabling continuous, postoperative treatment of acute, subacute and chronic spinal cord injury. The effort is funded by a $13.48 million grant from the Defense Advanced Research Projects Agency.
For difficult epilepsy cases, Johns Hopkins experts use the latest, less invasive diagnostic and treatment tools.
Johns Hopkins is among the few centers in the U.S. that identify tumors’ unique features using on-site fusion tests.
A new clinical trial set to begin in early 2021 at Johns Hopkins will test an innovative way of treating the devastating genetic disorder.
The technology used by the physicians for the augmented reality surgeries consisted of a headset with a see-through eye display that projects images of the patient’s internal anatomy such as bones and other tissue based on CT scans — essentially giving the surgeons X-ray vision.
